| Literature DB >> 30425165 |
Akiyuki Nishimura1,2,3,4, Tsukasa Shimauchi1,2,5, Tomohiro Tanaka1,2, Kakeru Shimoda1,2,3, Takashi Toyama1,4,6, Naoyuki Kitajima1,4, Tatsuya Ishikawa4,7, Naoya Shindo4, Takuro Numaga-Tomita1,2,3, Satoshi Yasuda8, Yoji Sato4,8, Koichiro Kuwahara9, Yoshito Kumagai6, Takaaki Akaike10, Tomomi Ide5, Akio Ojida4, Yasuo Mori11, Motohiro Nishida12,2,3,4.
Abstract
Defective mitochondrial dynamics through aberrant interactions between mitochondria and actin cytoskeleton is increasingly recognized as a key determinant of cardiac fragility after myocardial infarction (MI). Dynamin-related protein 1 (Drp1), a mitochondrial fission-accelerating factor, is activated locally at the fission site through interactions with actin. Here, we report that the actin-binding protein filamin A acted as a guanine nucleotide exchange factor for Drp1 and mediated mitochondrial fission-associated myocardial senescence in mice after MI. In peri-infarct regions characterized by mitochondrial hyperfission and associated with myocardial senescence, filamin A colocalized with Drp1 around mitochondria. Hypoxic stress induced the interaction of filamin A with the GTPase domain of Drp1 and increased Drp1 activity in an actin-binding-dependent manner in rat cardiomyocytes. Expression of the A1545T filamin mutant, which potentiates actin aggregation, promoted mitochondrial hyperfission under normoxia. Furthermore, pharmacological perturbation of the Drp1-filamin A interaction by cilnidipine suppressed mitochondrial hyperfission-associated myocardial senescence and heart failure after MI. Together, these data demonstrate that Drp1 association with filamin and the actin cytoskeleton contributes to cardiac fragility after MI and suggests a potential repurposing of cilnidipine, as well as provides a starting point for innovative Drp1 inhibitor development.Entities:
Year: 2018 PMID: 30425165 DOI: 10.1126/scisignal.aat5185
Source DB: PubMed Journal: Sci Signal ISSN: 1945-0877 Impact factor: 8.192